Get the Stockscreener App
65.53
2.23%
-1.495
Pre-market:
65.08
-0.45
-0.69%
Transmedics Group Inc stock is traded at $65.53, with a volume of 1.40M.
It is down -2.23% in the last 24 hours and up +7.39% over the past month.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.
See More
Previous Close:
$67.03
Open:
$66.57
24h Volume:
1.40M
Relative Volume:
0.63
Market Cap:
$2.20B
Revenue:
$401.09M
Net Income/Loss:
$32.64M
P/E Ratio:
69.71
EPS:
0.94
Net Cash Flow:
$-120.51M
1W Performance:
+5.74%
1M Performance:
+7.39%
6M Performance:
-52.86%
1Y Performance:
-26.11%
1-Day Range:
$64.34
$67.08
1-Week Range:
$58.54
$67.10
52-Week Range:
$55.00
$177.37
Transmedics Group Inc Stock (TMDX) Company Profile
Name
Transmedics Group Inc
Sector
Industry
Phone
(978) 552-0900
Address
200 MINUTEMAN ROAD, ANDOVER, MA
Compare TMDX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TMDX
Transmedics Group Inc
|
65.53 | 2.20B | 401.09M | 32.64M | -120.51M | 0.94 |
|
ABT
Abbott Laboratories
|
127.86 | 221.77B | 41.95B | 13.40B | 6.49B | 7.65 |
|
BSX
Boston Scientific Corp
|
102.71 | 151.38B | 15.91B | 1.79B | 1.89B | 1.21 |
|
SYK
Stryker Corp
|
391.07 | 149.08B | 21.97B | 3.59B | 3.21B | 9.33 |
|
MDT
Medtronic Plc
|
91.41 | 117.21B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
71.13 | 41.95B | 6.60B | 4.16B | 490.10M | 6.93 |
Transmedics Group Inc Stock (TMDX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-17-24 | Downgrade | JP Morgan | Overweight → Neutral |
| Nov-22-24 | Downgrade | Needham | Buy → Hold |
| Oct-29-24 | Reiterated | Needham | Buy |
| Oct-29-24 | Reiterated | Oppenheimer | Outperform |
| Sep-24-24 | Initiated | Robert W. Baird | Outperform |
| Aug-21-24 | Initiated | Needham | Buy |
| Jun-06-24 | Initiated | Cantor Fitzgerald | Overweight |
| Jun-04-24 | Initiated | Stephens | Overweight |
| Mar-28-24 | Initiated | Piper Sandler | Overweight |
| Jul-19-23 | Initiated | Robert W. Baird | Outperform |
| Aug-02-22 | Upgrade | JP Morgan | Neutral → Overweight |
| Oct-08-20 | Downgrade | JP Morgan | Overweight → Neutral |
| Apr-07-20 | Initiated | Oppenheimer | Outperform |
| May-28-19 | Initiated | Canaccord Genuity | Buy |
| May-28-19 | Initiated | Cowen | Outperform |
| May-28-19 | Initiated | JP Morgan | Overweight |
| May-28-19 | Initiated | Morgan Stanley | Equal-Weight |
View All
Transmedics Group Inc Stock (TMDX) Latest News
TransMedics Group (NASDAQ:TMDX) Shares Up 6.6%What's Next? - MarketBeat
TMDX BREAKING NEWS: BFA Law is Investigating TransMedics - GlobeNewswire
Bragar Eagel & Squire, P.C. Is Investigating Quanterix and TransMedics and Encourages Investors to Contact the Firm - GlobeNewswire
When (TMDX) Moves Investors should Listen - Stock Traders Daily
TransMedics Group, Inc. Announcement: If You Have Suffered - GlobeNewswire
TransMedics Group, Inc. Announcement: If You Have Suffered Losses in TransMedics Group, Inc. - The Bakersfield Californian
TransMedics Group, Inc. Announcement: If You Have Suffered Losses in TransMedics Group, Inc. (NASDAQ: TMDX), You Are Encouraged to Contact The Rosen Law Firm About Your Rights - GlobeNewswire Inc.
TransMedics Group (TMDX) Plunges Amidst Allegations of Fraud, Organ Trafficking – Hagens Berman - GlobeNewswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of TransMedics Group, Inc.TMDX - PR Newswire
TransMedics Group Inc (TMDX) Shares Up 4.31% on Jan 28 - GuruFocus.com
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against TransMedics Group, Inc. (TMDX) and Encourages Shareholders to Learn More About the Investigation - Markets Insider
Rosen Law Firm Encourages TransMedics Group, Inc. Investors to Inquire About Securities Class Action InvestigationTMDX - PR Newswire
TransMedics Group, Inc. Announcement: If You Have Suffered Losses in TransMedics Group, Inc. ... - Post Register
TMDX Stock Plunges 49.2% in Three Months: What's Behind the Downfall? - MSN
TransMedics Group (NASDAQ:TMDX) Stock Price Down 4.3%Here's What Happened - MarketBeat
TMDX INVESTIGATION: TransMedics Shares Remain Down - GlobeNewswire
TMDX INVESTIGATION: TransMedics Shares Remain Down Following Report by Scorpion Capital; Investors Encouraged - EIN News
TransMedics Group (NASDAQ:TMDX) Hits New 52-Week LowShould You Sell? - MarketBeat
TransMedics Group Inc (TMDX) Shares Up 6.12% on Jan 22 - GuruFocus.com
Wolf Haldenstein Adler Freeman & Herz LLP announces that it - GlobeNewswire
TransMedics Group (NASDAQ:TMDX) Hits New 1-Year LowHere's What Happened - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Encourages TransMedics Group, Inc. (TMDX) Stockholders to Inquire about Securities Investigation - Markets Insider
TMDX Stock Down Despite Responding to Misleading Short-Seller Report - MSN
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages TransMedics Group, Inc. Investors to Inquire About Securities Class Action Investigation – TMDX - Markets Insider
TMDX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces an Investigation into TransMedics Group, Inc. and Encourages Investors to Contact the Firm - Markets Insider
TransMedics Group (NASDAQ:TMDX) Hits New 12-Month LowWhat's Next? - MarketBeat
Rosen Law Firm Encourages TransMedics Group, Inc. Investors to I - GuruFocus.com
Returns Are Gaining Momentum At TransMedics Group (NASDAQ:TMDX) - Simply Wall St
Indo-Asian News Service - IANS India Pvt Ltd
When the Price of (TMDX) Talks, People Listen - Stock Traders Daily
Brokerages Set TransMedics Group, Inc. (NASDAQ:TMDX) Target Price at $122.70 - MarketBeat
TransMedics Group, Inc. (NASDAQ:TMDX) Given Average Recommendation of “Moderate Buy” by Brokerages - Defense World
TransMedics: Expectations Remain Sky-High Despite Recent Stock Drop - Seeking Alpha
TransMedics Group (NASDAQ:TMDX) Reaches New 1-Year LowHere's Why - MarketBeat
Looking At TransMedics Gr's Recent Unusual Options Activity - Benzinga
TMDX Stock Touches 52-Week Low at $58.27 Amid Market Challenges - MSN
TMDX Investigation Reminder: Kessler Topaz Meltzer & Check, LLP - GuruFocus.com
Why TransMedics Fell 15.7% This Week - MSN
TMDX Investigation Reminder: Kessler Topaz Meltzer & Check, LLP Encourages TransMedics Group, Inc. (NASDAQ: TMDX) Investors with Significant Losses to Contact the Firm - Finansavisen
Why TransMedics Group (TMDX) Stock is Moving Today - GuruFocus.com
Transmedics (TMDX) Fell on Investors’ Growing Concerns - Yahoo Finance
TMDX Investors Have Opportunity to Join TransMedics Group, Inc. Securities Fraud Investigation with the Schall Law Firm - PR Newswire
TMDX Stock Touches 52-Week Low at $58.27 Amid Market Challenges By Investing.com - Investing.com South Africa
Transmedics Group Inc Stock (TMDX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Transmedics Group Inc Stock (TMDX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Khayal Tamer I | Chief Commercial Officer |
Jan 07 '25 |
Sale |
80.05 |
1,083 |
86,694 |
20,843 |
| Khayal Tamer I | Chief Commercial Officer |
Dec 02 '24 |
Option Exercise |
13.28 |
1,084 |
14,396 |
21,927 |
| Khayal Tamer I | Chief Commercial Officer |
Dec 02 '24 |
Sale |
86.40 |
1,084 |
93,658 |
20,843 |
| Khayal Tamer I | Chief Commercial Officer |
Nov 11 '24 |
Option Exercise |
38.46 |
1,458 |
56,075 |
22,301 |
| Khayal Tamer I | Chief Commercial Officer |
Nov 11 '24 |
Sale |
90.04 |
1,458 |
131,278 |
20,843 |
| Basile Edward M | Director |
Nov 05 '24 |
Option Exercise |
28.12 |
6,750 |
189,810 |
7,482 |
| Basile Edward M | Director |
Nov 05 '24 |
Sale |
83.55 |
6,750 |
563,994 |
732 |
| Khayal Tamer I | Chief Commercial Officer |
Nov 01 '24 |
Option Exercise |
13.28 |
1,083 |
14,382 |
21,926 |
| Khayal Tamer I | Chief Commercial Officer |
Nov 01 '24 |
Sale |
82.64 |
1,083 |
89,499 |
20,843 |
0.35%
0.29%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):